PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate Cancer

被引：0
|
作者：
Murphy, Declan G. [1 ,2 ]
Emmett, Louise [3 ]
机构：
[1] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic, Australia
[3] St Vincents Hosp, Dept Theranost & Nucl Med, Sydney, NSW, Australia
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2024.06.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页码：642 / 645
页数：4
相关论文
共 50 条
  • [41] Prostate Specific Antigen response to neoadjuvant Lutetium-177-PSMA treatment in high-risk localized prostate cancer patients
    Frumer, M.
    Kedar, D.
    Baniel, J.
    Groshar, D.
    Bernstine, H.
    Yakimov, M.
    Rosenbaum, E.
    Golan, S.
    EUROPEAN UROLOGY, 2023, 83
  • [42] [68Ga]PSMA-11 PET findings in intermediate/high risk prostate cancer patients at staging
    Scarale, A.
    Capitanio, S.
    Franchini, A.
    Potami, M. A.
    Longoni, M.
    Tappero, S.
    Gay, E.
    Cabrini, G.
    Milella, M.
    Dell'Oglio, P.
    Galfano, A.
    Bocciardi, A. M.
    Rossetti, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S455 - S455
  • [43] Ga68-PSMA PET for lymph node staging in intermediate and high-risk prostate cancer patients undergoing robotic assisted radical prostatectomy
    Spena, Gianluca
    Moretti, Tomas B.
    Davila, Francisco S.
    Dos Anjos, Gabriel
    Khan, Ilaana
    Calace, Francesco P.
    Aveta, Achille
    Ndolfo, Savio D. Pa
    Tufano, Antonio
    Izzo, Alessandro
    Farias, Artur
    Perdona, Sisto
    Maes, Kris
    MINERVA UROLOGY AND NEPHROLOGY, 2024, 76 (04): : 467 - 473
  • [44] 18F-Florastamin PET/CT for the initial staging of patients with high-risk prostate cancer
    Choi, W. H.
    Boo, S.
    Choi, Y.
    Kim, H.
    Lee, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S460 - S460
  • [45] The role of 68Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate cancer: for all high-risk patients or would it be better to select them?
    Monteiro, Fernando Sabino M.
    Serafim Eliam, Jucara Motta
    de Jesus, Rafaela Gomes
    Cavalcante, Pedro
    Gomes, Gustavo do Vale
    Hochhegger, Bruno
    Goncalves, Vinicius K.
    Freitas, Laura Von Wallwitz
    Roman, Diego H.
    Fay, Andre Poisl
    PROSTATE INTERNATIONAL, 2021, 9 (01) : 54 - 59
  • [46] 68Ga-PSMA PET-CT in patients with newly diagnosed high-risk prostate cancer
    Koulikov, Victoria
    Barnes, Sophie
    Even-Sapir, Einat
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [47] PSMA PET–CT in initial prostate cancer staging
    Frederik A. Verburg
    Andreas Pfestroff
    Nature Reviews Urology, 2016, 13 : 498 - 499
  • [48] Surgery for high-risk localized prostate cancer
    Schmitges, Jan
    Trinh, Quoc-Dien
    Walz, Jochen
    Graefen, Markus
    THERAPEUTIC ADVANCES IN UROLOGY, 2011, 3 (04) : 173 - 182
  • [49] Chemotherapy for localized, high-risk prostate cancer
    Narayan, S
    Smith, DC
    Sandler, HM
    SEMINARS IN RADIATION ONCOLOGY, 2003, 13 (02) : 152 - 157
  • [50] Management of High-Risk Localized Prostate Cancer
    Marciscano, Ariel E.
    Hardee, Matthew E.
    Sanfilippo, Nicholas
    ADVANCES IN UROLOGY, 2012, 2012
12345